1. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979. 16:101–116.
Article
2. Shapiro F. Osteogenesis imperfecta in pediatric orthopedic deformities. 2001. Boston: Academic Press;847–860.
3. Glorieux FH, Rauch F, Plotokin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000. 15:1650–1658.
Article
4. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley P, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002. 17:30–38.
Article
5. Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 2002. 31:12–18.
Article
6. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004. 363:1377–1387.
Article
8. National Anthropometric Survey of Korea. 1997. Retrieved January 24, 2006. Seoul, Korea: Korean Agency for Technology and Standards;
http://www.standard.go.kr
.
9. Cho TJ, Choi IH, Chung CY, Yoo WJ, Park MS, Park YK. Efficacy of oral alendronate in children with osteogenesis imperfecta. J Pediatr Orthop. 2005. 25:607–612.
Article
10. Cho TJ, Park MS, Choi IH, Chung CY, Yoo WJ. Efficacy of cyclic intravenous pamidronate therapy for children with osteogenesis imperfecta. J Korean Orhtop Assoc. 2003. 38:741–747.
Article
11. Fassier AM, Rauch F, Aarabi M, Janelle C, Fassier F. Radial head dislocation in osteogenesis imperfecta. Proceedings of the 9th International Conference on Osteogenesis Imperfecta. 2005. 95.
12. Campbell CC, Waters PM, Emans JB. Excision of the radial head for congenital dislocation. J Bone Joint Surg Am. 1992. 74:726–733.
Article
13. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998. 339:947–952.
Article
14. Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V. Bone. 2006. 38:13–20.
Article
15. Fleming F, Woodhead HJ, Briody JN, Hall J, Cowell CT, Ault J, Kozlowski K, Sillence DO. Cyclic bisphosphonate therapy in osteogenesis imperfecta type V. J Paediatr Child Health. 2005. 41:147–151.
Article